Ultralife (ULBI) Q2 Revenue Rises 13%

Ultralife (NASDAQ:ULBI), a specialty battery and communications systems manufacturer, reported its second quarter 2025 earnings on August 7, 2025, covering the period ended June 30. The report showed headline revenue (GAAP) grew 13.0% to $48.6 million, driven by the Electrochem acquisition. However, that figure missed analysts’ estimates, which expected $51.0 million in GAAP revenue. Adjusted EPS came in at $0.07, significantly below the $0.13 consensus non-GAAP EPS estimate. The company also saw tighter margins and lower profits (GAAP) compared to Q2 2024. Overall, the quarter reflected gains from recent acquisitions, but organic growth was muted and operating challenges remained in place. Source: Analyst estimates for the quarter provided by FactSet. Ultralife is known for designing and manufacturing specialty batteries and communications systems. Its products serve a range of markets, including government and defense, medical, industrial, and energy sectors. The company operates through two main segments: Battery & Energy Products and Communications Systems.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool